QA: Elevance Health Inc in us_non_life/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001156039_2023_Elevance_Health_Inc.pdf

Logs

warning Large missing amount for aggregate "Revenues" added to remainder. industry.us_generic {'missing_ratio': 104.45117845117845, 'aggregate_val': 156595000000, 'exp_sum': 1485000000, 'exp_to_value': {'PremiumsEarned': 0, 'InvestmentIncome': 1485000000, 'InsuranceCommissionsAndFees': 0, 'remainder_Revenues': 0}}

Graph

Absolute values for 0001156039, Elevance Health Inc

  xvar xval
0 Investments 0
1 SeparateAccountAssets 0
2 PremiumsReceivable 7,083,000,000
3 DeferredPolicyAcquisitionCosts 0
4 ReinsuranceRecoverables 0
5 IntangibleAssets 34,698,000,000
6 AssetsCurrent 55,617,000,000
7 AssetsNonCurrent 4,316,000,000
8 remainder_Assets 1,058,000,000
9 LiabilityForClaimsAndClaimsAdjustmentExpense 16,333,000,000
10 PolicyholderContractDeposits 5,933,000,000
11 LiabilitiesCurrent 39,696,000,000
12 UnearnedPremiums 1,112,000,000
13 ReinsurancePayable 0
14 LongTermDebt 23,911,000,000
15 remainder_Liabilities -20,607,000,000
16 PolicyholderBenefitsAndClaims 118,489,819,013
17 SellingGeneralAndAdministrativeExpense 31,082,366,108
18 DeferredPolicyAcquisitionCostAmortizationExpense 0
19 remainder_Expenses 3,312,005,035
20 PremiumsEarned 0
21 InvestmentIncome 1,496,138,749
22 InsuranceCommissionsAndFees 0
23 remainder_Revenues 160,331,494,396
24 Revenues_Y1 160,646,674,842
25 Revenues_Y2 161,562,770,847
26 Revenues_Y3 161,770,078,674
27 Revenues_Y4 161,817,007,965
28 Revenues_Y5 161,827,633,145
29 remainder_NetIncome 0
30 remainder_ComprehensiveNetIncome -2,027,263,186
  yvar yval
0 Assets 102,772,000,000
1 Liabilities 66,378,000,000
2 Expenses 152,884,190,156
3 Revenues 161,827,633,145
4 StockholdersEquity 36,394,000,000
5 NetIncome 8,943,442,989
6 ComprehensiveNetIncome 7,929,811,397
7 BaseVar 4,459,424,260,860
8 EconomicCapitalRatiobeforeLimitedLiability 0.663
9 EconomicCapitalRatio 1.33

Edgar->Model Mapping

Feature Distribution

Company Valuation

Change over Time